{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:42:44Z","timestamp":1792032164998,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.psychres.2025.116684","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:15:31Z","timestamp":1754925331000},"page":"116684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Polypharmacy in clozapine-treated patients: A retrospective analysis of 667 patients in Ottawa, Canada"],"prefix":"10.1016","volume":"352","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-221X","authenticated-orcid":false,"given":"Nicholas","family":"Preobrazenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TiChen","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-6790","authenticated-orcid":false,"given":"Helen","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3932-1780","authenticated-orcid":false,"given":"Olabisi","family":"Owoeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psychres.2025.116684_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9872936","article-title":"Population pharmacokinetics of clozapine: a systematic review","volume":"2020","author":"Albitar","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2025.116684_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00115-018-0507-3","article-title":"Pharmacological treatment for schizoaffective disorder: A comparison with schizophrenia and bipolar disorder","volume":"90","author":"Assion","year":"2019","journal-title":"Nervenarzt."},{"issue":"3","key":"10.1016\/j.psychres.2025.116684_bib0003","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/bcpt.13384","article-title":"Polypharmacy in schizophrenia","volume":"126","author":"Baandrup","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.psychres.2025.116684_bib0004","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1192\/bjp.2024.140","article-title":"Clozapine, relapse, and adverse events: a 10-year electronic cohort study in Canada","volume":"225","author":"Balbuena","year":"2024","journal-title":"Br. J. Psychiatry"},{"issue":"49","key":"10.1016\/j.psychres.2025.116684_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21490","article-title":"Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness","volume":"21","author":"Barnes","year":"2017","journal-title":"Health Technol. Assess. (Winch. Engl.)"},{"issue":"4","key":"10.1016\/j.psychres.2025.116684_bib0006","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/oxfordjournals.schbul.a006901","article-title":"When symptoms persist: clozapine augmentation strategies","volume":"27","author":"Buckley","year":"2001","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116684_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1478625","article-title":"Knowledge domain and trends in treatment-resistant schizophrenia (TRS) research based on CiteSpace bibliometrics analysis","volume":"15","author":"Cai","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.psychres.2025.116684_bib0008","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1017\/S1461145712000399","article-title":"Critical review of antipsychotic polypharmacy in the treatment of schizophrenia","volume":"17","author":"Fleischhacker","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.psychres.2025.116684_bib0009","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S2215-0366(24)00314-6","article-title":"Prevalence, correlates, tolerability-related outcomes, and efficacy-related outcomes of antipsychotic polypharmacy: a systematic review and meta-analysis","volume":"11","author":"H\u00f8jlund","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2025.116684_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.schres.2021.01.015","article-title":"Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients","volume":"228","author":"L\u00e4hteenvuo","year":"2021","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.psychres.2025.116684_bib0011","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40265-021-01556-4","article-title":"Antipsychotic polypharmacy for the management of schizophrenia: evidence and recommendations","volume":"81","author":"L\u00e4hteenvuo","year":"2021","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.psychres.2025.116684_bib0012","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/070674371506001107","article-title":"Subtyping schizophrenia by treatment response: antipsychotic development and the Central role of positive symptoms","volume":"60","author":"Lee","year":"2015","journal-title":"Can. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116684_bib0013","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/ps.2009.60.2.210","article-title":"Treatment patterns for schizoaffective disorder and schizophrenia among Medicaid patients","volume":"60","author":"Olfson","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2025.116684_bib0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences","volume":"12","author":"Pazan","year":"2021","journal-title":"Eur. Geriatr. Med."},{"issue":"5","key":"10.1016\/j.psychres.2025.116684_bib0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00228-020-02830-2","article-title":"Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia","volume":"76","author":"Puranen","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2025.116684_bib0016","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the pharmacotherapy of schizophrenia in adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2025.116684_bib0017","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0706743717718167","article-title":"Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis","volume":"62","author":"Siskind","year":"2017","journal-title":"Can. J. Psychiatry - Rev. Can. Psychiatr."},{"issue":"5","key":"10.1016\/j.psychres.2025.116684_bib0018","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1192\/pb.26.5.170","article-title":"Co-prescribing of atypical and typical antipsychotics \u2013 prescribing sequence and documented outcome","volume":"26","author":"Taylor","year":"2002","journal-title":"Psychiatr. Bull."},{"issue":"2","key":"10.1016\/j.psychres.2025.116684_bib0019","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/schbul\/sbae113","article-title":"Evaluating reduced blood monitoring frequency and the detection of hematological abnormalities in clozapine-treated patients with schizophrenia: A chart review study from the COVID-19 pandemic","volume":"51","author":"Thai","year":"2025","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.psychres.2025.116684_bib0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/FPC.0000000000000347","article-title":"PharmGKB summary: clozapine pathway, pharmacokinetics","volume":"28","author":"Thorn","year":"2018","journal-title":"Pharmacogenet. Genom."},{"issue":"7","key":"10.1016\/j.psychres.2025.116684_bib0021","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMa Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125003324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125003324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:38:34Z","timestamp":1779943114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125003324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":21,"alternative-id":["S0165178125003324"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116684","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypharmacy in clozapine-treated patients: A retrospective analysis of 667 patients in Ottawa, Canada","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116684"}}